Zobrazeno 1 - 10
of 1 692
pro vyhledávání: '"Haiyan XU"'
Publikováno v:
ACS Omega, Vol 9, Iss 50, Pp 49683-49691 (2024)
Externí odkaz:
https://doaj.org/article/f4c464b9525e4d4f970167e85f6e71bd
Autor:
Siyu Lei, Linyan Tian, Lu Yang, Yaning Yang, Junling Li, Xingsheng Hu, Xuezhi Hao, Haiyan Xu, Yan Wang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Selective RET inhibitors have been approved by the Chinese government for the treatment of RET-rearranged non-small cell lung cancer. This study aimed to illustrate the efficacy and safety of selective RET inhibitors in a real-wor
Externí odkaz:
https://doaj.org/article/ea64b2d7a2634d2ea71250e7f13e4922
Autor:
Yu Xiao, Tao Pan, Wuren Da, Yuanding Liu, Shuangya Chen, Daiquan Chen, Keying Liu, Yihan Zheng, Daolong Xie, Yuan Gao, Haiyan Xu, Yang Sun, Weihong Tan
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-17 (2024)
Abstract Pancreatic cancer is one of the most malignant tumors with the highest mortality rates, and it currently lacks effective drugs. Aptamer-drug conjugates (ApDC), as a form of nucleic acid drug, show great potential in cancer therapy. However,
Externí odkaz:
https://doaj.org/article/f0c9c33f078a4b5887a52fa7832198b0
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background Surgeries for treating pelvic organ prolapse involving the utilization of synthetic mesh have been associated with complications such as mesh erosion, postoperative pain, and dyspareunia. This work aimed to reduce the surgical imp
Externí odkaz:
https://doaj.org/article/d4a6872448ff458998a1ac98a2cbe9d3
Autor:
Lei Yang, Jiawen Shi, Mingyang Zhong, Pingping Sun, Xiaojing Zhang, Zhengyi Lian, Hang Yin, Lijun Xu, Guyin He, Haiyan Xu, Han Wu, Ziheng Wang, Kai Miao, Jianfei Huang
Publikováno v:
Cellular & Molecular Biology Letters, Vol 29, Iss 1, Pp 1-22 (2024)
Abstract Objective Colorectal cancer (CRC) is a form of malignancy that exhibits a comparatively elevated occurrence and fatality rate. Given the relatively slower progress in diagnostic and therapeutic approaches for CRC, there is a need to investig
Externí odkaz:
https://doaj.org/article/f6089bb2051847afab42d9c82d2d5e9d
Publikováno v:
Materials Today Bio, Vol 29, Iss , Pp 101282- (2024)
As the most aggressive and metastatic subtype of breast cancer, clinical demands of triple negative breast cancer (TNBC) have far not been met. Heat shock protein 60 (HSP60) is over expressed in tumor cells and impair the efficacy of photothermal the
Externí odkaz:
https://doaj.org/article/968e732d2eee4f16b451916a304a2584
Autor:
Fatima Dakroub, Firas Kobeissy, Stefania Mondello, Zhihui Yang, Haiyan Xu, Livia Sura, Candace Rossignol, Mehmet Albayram, Dhanashree Rajderkar, Kevin Wang, Michael D. Weiss
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Neonatal Encephalopathy (NE) is a major cause of lifelong disability and neurological complications in affected infants. Identifying novel diagnostic biomarkers in this population may assist in predicting MRI injury and differentiate neonate
Externí odkaz:
https://doaj.org/article/6e4fd04e4f6e49f48e51105eef83c8a3
Autor:
Weiyu Ge, Yanling Wang, Ming Quan, Tiebo Mao, Evelyne Y. Bischof, Haiyan Xu, Xiaofei Zhang, Shumin Li, Ming Yue, Jingyu Ma, Haiyan Yang, Lei Wang, Zhengyuan Yu, Liwei Wang, Jiujie Cui
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Background Pancreatic adenocarcinoma (PC) is an aggressive malignancy with limited treatment options. The poor prognosis primarily stems from late-stage diagnosis and when the disease has become therapeutically challenging. There is an urgen
Externí odkaz:
https://doaj.org/article/d88ac45d46cb4a8a8f4f248cd3e0d370
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-16 (2024)
Abstract Photothermal therapy (PTT) is a cancer-targeted treatment approach.The occurrence of tumors may be related to microbial infections (Viruses, bacteria, fungi, etc.), which probably provokes anti-tumor immunity. However, T cells in the context
Externí odkaz:
https://doaj.org/article/8d968ca9bc4e4aef8ac3361f8ca5749b
Autor:
Xingshan Zhao, Yidan Zhu, Zheng Zhang, Guizhou Tao, Haiyan Xu, Guanchang Cheng, Wen Gao, Liping Ma, Liping Qi, Xiaoyan Yan, Haibo Wang, Qingde Xia, Yuwang Yang, Wanke Li, Juwen Rong, Limei Wang, Yutian Ding, Qiang Guo, Wanjun Dang, Chen Yao, Qin Yang, Runlin Gao, Yangfeng Wu, Shubin Qiao, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 3, Pp 312-319 (2024)
Abstract. Background:. A phase II trial on recombinant human tenecteplase tissue-type plasminogen activator (rhTNK-tPA) has previously shown its preliminary efficacy in ST elevation myocardial infarction (STEMI) patients. This study was designed as a
Externí odkaz:
https://doaj.org/article/af60b554061644d98c978c015b31e2d3